{"url_path":"/sec/adil/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1513525/0001213900-26-053907-index.html","accession_number":"0001213900-26-053907","cik":"0001513525","ticker":"ADIL","issuer_name":"ADIAL PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1513525/0001213900-26-053907-index.html","primary_entity_key":"0001513525","primary_entity_name":"ADIAL PHARMACEUTICALS, INC."},"word_count":89,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings.\n\n \n\nFrom time to time, we may become involved in legal\nproceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings\nthat, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results,\nfinancial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement\ncosts, diversion of management resources and other factors."}